MannKind reported $1.83M in Interest Income for its fiscal quarter ending in June of 2025.


Interest Income Change Date
Adma Biologics USD 400K 198K Jun/2025
Dynavax Technologies USD 7.74M 675K Mar/2025
Eli Lilly USD 40M 8.3M Jun/2025
Insmed 0 0 Mar/2025
MacroGenics 1.41M 1.41M Jun/2025
MannKind USD 1.83M 124K Jun/2025
Merck USD 109M 37M Mar/2025
Novo Nordisk 3.42B 2.04B Mar/2025
Pfizer USD 156M 13M Jun/2025
Sanofi 76M 10M Jun/2025
Xencor USD 7.25M 290K Jun/2025